|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 16 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 10 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 11 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 10 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 10 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 14 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 10 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 9 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 9 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 6 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 5 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 8 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 7 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 6 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 5 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 4 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stoppedvista 9 veces74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Agosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 9 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 7 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 7 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 8 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 10 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 10 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 9 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 11 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 11 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 8 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 10 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 5 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 7 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 6 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 9 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 7 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 1 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 10 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 8 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 9 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 14 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Choroidal hemangioma 10 year old black malevista 10 veces10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAgosto 13, 2025
|
|
Choroidal hemangioma 10 year old black malevista 11 veces10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAgosto 13, 2025
|
|
Choroidal hemangioma 10 year old black malevista 10 veces10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAgosto 13, 2025
|
|
Roth Spot and Endocarditisvista 7 veces70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAgosto 13, 2025
|
|
Roth Spot and Endocarditisvista 5 veces70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAgosto 13, 2025
|
|
Roth Spot and Endocarditisvista 6 veces70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAgosto 13, 2025
|
|
Roth Spot and Endocarditisvista 8 veces70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAgosto 13, 2025
|
|
Roth Spot and Endocarditisvista 4 veces70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAgosto 13, 2025
|
|
Choroidal Nevus with Halovista 12 vecesAgosto 13, 2025
|
|
Choroidal Nevus with Halovista 7 vecesAgosto 13, 2025
|
|
Choroidal Nevus with Halovista 12 vecesAgosto 13, 2025
|
|
Choroidal Nevus with Halovista 9 vecesAgosto 13, 2025
|
|
CRAO and NVI (rubeosis)vista 4 vecesAgosto 13, 2025
|
|
CRAO and NVI (rubeosis)vista 14 vecesAgosto 13, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 15 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 13 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 16 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 13 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 7 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 16 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 7 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 8 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 11 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 10 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 8 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 9 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vista 14 veces23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 15 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 15 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 11 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 10 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 14 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 12 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 15 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 14 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 12 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 9 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 13 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vista 16 veces48 year old female with bear tracks in her retina and NPDR.Julio 28, 2025
|
|
Small choroidal melanomavista 11 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 14 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 13 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 10 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 11 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 18 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 12 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 9 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 8 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 11 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 13 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 13 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 8 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 13 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Small choroidal melanomavista 19 veces28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Julio 28, 2025
|
|
Acute retinal necrosisvista 12 veces67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJulio 28, 2025
|
|
Acute retinal necrosisvista 11 veces67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJulio 28, 2025
|
|
Acute retinal necrosisvista 12 veces67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJulio 28, 2025
|
|
| 17549 archivos en 176 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
